Arkolith/Insider Trading/TSHA/Form 4

Nolan Sean P.

Chief Executive Officer, DirectorTaysha Gene Therapies, Inc. (TSHA) · full profile →Form 4 · filed Jan 27, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$840K
Net Open-Market Flow
-$840K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2026Sell(S)41K$4.61$190K2.9M
Jan 23, 2026Sell(S)137K$4.75$650K2.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001569926-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML